Comparative Pharmacology
Head-to-head clinical analysis: LIDOCAINE HYDROCHLORIDE 0 4 IN DEXTROSE 5 IN PLASTIC CONTAINER versus NAROPIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LIDOCAINE HYDROCHLORIDE 0 4 IN DEXTROSE 5 IN PLASTIC CONTAINER versus NAROPIN.
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER vs NAROPIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lidocaine is a sodium channel blocker that inhibits depolarization of cardiac myocytes and nerve axons by binding to voltage-gated sodium channels and stabilizing the neuronal membrane, thereby preventing the propagation of action potentials.
Ropivacaine blocks sodium ion channels in neuronal cell membranes, inhibiting the conduction of nerve impulses.
Intravenous infusion: 1-4 mg/min (20-50 mcg/kg/min) for cardiac arrhythmias. Bolus: 1-1.5 mg/kg IV, then infusion.
Epidural administration: Initial dose 20-30 mL of 0.5% solution (100-150 mg) followed by 10-15 mL/hour of 0.2% solution for continuous infusion. Maximum single dose: 200 mg. Maximum daily dose: 400 mg.
None Documented
None Documented
Terminal elimination half-life approximately 1.5-2 hours after bolus, prolonged to 2-4 hours in heart failure or hepatic impairment; continuous infusion may show context-sensitive half-life.
Terminal elimination half-life: 4.2 ± 1.1 hours (adults) for ropivacaine. Clinical context: prolonged half-life in neonates (up to 12-18 hours) due to immature hepatic clearance; consider accumulation with continuous infusion in renal impairment (though minimal unchanged drug).
Renal excretion of unchanged drug and metabolites; <10% unchanged in urine, >90% as metabolites (primarily monoethylglycinexylidide and glycinexylidide). Biliary/fecal elimination minimal (<1%).
Renal: 86-93% as metabolites (including 3-hydroxyropivacaine, 4-hydroxyropivacaine, and 2',6'-pipecoloxylidide), <1% unchanged. Biliary/fecal: <10% collectively, primarily as metabolites.
Category A/B
Category C
Local Anesthetic / Antiarrhythmic (Class Ib)
Local Anesthetic